Skip to main content

The BCG Lesson

ON JANUARY 2006, France became sole user of BCG vaccine Statens Serum Institut (SSI) for tuberculosis vaccination. Not long after, rapid increase in cases of adverse reactions (ADRs) came up; such as abscesses (in 73 percent of patients treated), around 30 percent had local reactions (lymphadenopathy of above one cm in size), while 20 patients developed suppurative lymphadenopathy.
 
Christelle Chol, leader of those who followed the patients for two years, found that the ADRs became consistent a year after their appearance or detection. They published their findings at the Pharmacoepidemiology and Drug Safety (Dec 5).
 
BCG vaccine—or Bacillus Calmette-Guerin (named after its discoverers)—contains weakened but alive strain of Mycobacterium bovis (a strain found in pigs). Because the bacteria can still stimulate reaction from a person’s immune system (without causing disease), it prepares the body to combat and destroy tuberculosis bacteria upon exposure. Studies in 1994 to 1995 showed a protective rate of 60 to 80 percent.
 
A clinical trial (1966) in the United States (Georgia and Alabama), however, showed only an efficacy of 14 percent. This figure left the authorities unconvinced in the use of BCG for mass vaccination there. Another trial (1979) in South India showed no efficacy at all.
 
And now we have these ADRs occurring in France. It might just be a case of contamination like what happened in 1930 (the first ever mass immunization using BCG also in France) where almost all of 240 infants immunized developed tuberculosis, resulting to 72 deaths. But this time, the French authorities believed that the ADRs came from the vaccine formulation itself.
 
The French problem is one of the many stories that highlight the dangers of synthetic medicines to health and life vis-à-vis their obvious accomplishments in chemotherapeutics. It tells of... [READ MORE]
 
This article appears in SunStar Cebu newspaper on 20 February 2013. 

Labels

Labels:

Comments

Post a Comment

Popular Posts

Deadly X-Gene Mutants

A RECENT study on macrophages (i.e. defensive cells in our body that engulf threatening substances inside our body) introduced me to a lethal, genetic disease that targets the male population. This disease is called Duchenne muscular dystrophy (DMD), named after the French neurologist Guillaume Benjamin Amand Duchenne, who described it in 1861. While it has an incidence of one in 3,500 newborn males, health experts consider this as the most common lethal disease of childhood around the world. Mutation in the male (X) chromosome [dystrophin gene, locus Xp21] causes a rapid degeneration of the muscles, leading into an eventual loss of walking ability and then death. While females do not exhibit symptoms, they can be carriers of these defective genes, especially if the father had this condition or the mother is also a carrier. Symptoms usually appear before age five; at times visible in early infancy. These symptoms involve... ( Read more .)  This article appears in Sun-Star Ce...
Post a Comment
Read more

Joy, Temperance and Repose

“I RECKON being ill as one of the great pleasures of life, provided one is not too ill and is not obliged to work till one is better,” wrote Samuel Butler in The Way of All Flesh (1903). The term “antioxidant” was originally used in the 18th century to refer to a chemical that prevents the consumption of oxygen in laboratory experiments. However, in the late 19th and early 20th century, extensive study exploded... ( Read more ) This article appeared in SunStar Cebu newspaper on 02 June 2010.
Post a Comment
Read more